Literature DB >> 23314547

Influence of spurious hemolysis on blood gas analysis.

Giuseppe Lippi1, Rossana Fontana, Paola Avanzini, Franca Sandei, Luigi Ippolito.   

Abstract

BACKGROUND: Although the prevalence of hemolyzed samples referred for blood gas analysis is as high as 4%, no studies have assessed the bias introduced by spurious erythrocyte breakdown, nor it is known which parameters are mostly influenced and to what extent. This study was hence planned to assess the influence of spurious hemolysis on venous blood gas analysis.
METHODS: Venous blood was collected from nine healthy volunteers in sodium heparin tubes and divided in two aliquots of 3 mL. The former aliquot was mechanically hemolyzed by aspiration with 0.5 mL insulin syringe equipped with 30 gauge needle. One milliliter of all aliquots was tested for hemoglobin, pH, oxygen partial pressure (pO₂), partial pressure of carbon dioxide (pCO₂), bicarbonate (HCO³⁻), oxygen tension at 50% hemoglobin saturation (p50), oxygen saturation (sO₂), actual base excess (ABE), carboxyhemoglobin (COHb), methemoglobin (metHb), ionized calcium (Ca²⁺) and potassium, on ABL800 flex. The remaining 2 mL of blood were centrifuged, plasma separated and tested for hemolysis index.
RESULTS: The concentration of cell-free hemoglobin increased from <0.5 g/L to 8.9±1.5 g/L in hemolyzed aliquots. In hemolyzed blood, significant decreases were found for pH (-0.2%), pO₂ (-4.9%), sO₂ (-4.9%), COHb (-11%) and Ca²⁺ (-7.0%), whereas significant increases were observed for pCO₂ (+4.1%), HCO³⁻ (+1.4%) and potassium (+152%). Clinically meaningful bias was found for pO₂, pCO₂, Ca²⁺ and potassium.
CONCLUSIONS: Spurious hemolysis is likely to introduce meaningful biases in blood gas analysis, hence manufacturers of blood gas analyzers should develop instrumentation capable of identifying interfering substances in whole blood. The presence of spurious hemolysis should also be suspected whenever test results do not reflect the clinics.

Entities:  

Mesh:

Substances:

Year:  2013        PMID: 23314547     DOI: 10.1515/cclm-2012-0802

Source DB:  PubMed          Journal:  Clin Chem Lab Med        ISSN: 1434-6621            Impact factor:   3.694


  7 in total

Review 1.  Blood gas testing and related measurements: National recommendations on behalf of the Croatian Society of Medical Biochemistry and Laboratory Medicine.

Authors:  Lora Dukić; Lara Milevoj Kopčinović; Adrijana Dorotić; Ivana Baršić
Journal:  Biochem Med (Zagreb)       Date:  2016-10-15       Impact factor: 2.313

2.  Comparison of two portable clinical analyzers to one stationary analyzer for the determination of blood gas partial pressures and blood electrolyte concentrations in horses.

Authors:  Katharina Kirsch; Johann Detilleux; Didier Serteyn; Charlotte Sandersen
Journal:  PLoS One       Date:  2019-02-15       Impact factor: 3.240

3.  Hemolysis Interference Studies: The Particular Case of Sodium Ion.

Authors:  José Antonio Delgado; Daniel Morell-Garcia; Josep Miquel Bauça
Journal:  EJIFCC       Date:  2019-03-01

4.  The Influence of Training Load on Hematological Athlete Biological Passport Variables in Elite Cyclists.

Authors:  Tiffany Astolfi; Fabienne Crettaz von Roten; Bengt Kayser; Martial Saugy; Raphael Faiss
Journal:  Front Sports Act Living       Date:  2021-03-18

5.  Leukocytosis interference in clinical chemistry: Shall we still interpret test results without hematological data?

Authors:  Guillaume Grzych; Estelle Roland; David Beauvais; Patrice Maboudou; Giuseppe Lippi
Journal:  J Med Biochem       Date:  2020-01-10       Impact factor: 3.402

6.  Institutional practices and policies in acid-base testing: a self reported Croatian survey study on behalf of the Croatian society of medical biochemistry and laboratory medicine Working Group for acid-base balance.

Authors:  Lora Dukić; Ana-Maria Simundić
Journal:  Biochem Med (Zagreb)       Date:  2014-06-15       Impact factor: 2.313

7.  Time-dependent variation of ionized calcium in serum samples.

Authors:  Antonija Perović; Marina Njire Bratičević
Journal:  Biochem Med (Zagreb)       Date:  2019-10-15       Impact factor: 2.313

  7 in total

北京卡尤迪生物科技股份有限公司 © 2022-2023.